1. Home
  2. CVRX vs CPSS Comparison

CVRX vs CPSS Comparison

Compare CVRX & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • CPSS
  • Stock Information
  • Founded
  • CVRX 2000
  • CPSS 1991
  • Country
  • CVRX United States
  • CPSS United States
  • Employees
  • CVRX N/A
  • CPSS N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CPSS Finance: Consumer Services
  • Sector
  • CVRX Health Care
  • CPSS Finance
  • Exchange
  • CVRX Nasdaq
  • CPSS Nasdaq
  • Market Cap
  • CVRX 181.5M
  • CPSS 193.8M
  • IPO Year
  • CVRX 2021
  • CPSS 1992
  • Fundamental
  • Price
  • CVRX $6.35
  • CPSS $9.02
  • Analyst Decision
  • CVRX Buy
  • CPSS
  • Analyst Count
  • CVRX 7
  • CPSS 0
  • Target Price
  • CVRX $14.50
  • CPSS N/A
  • AVG Volume (30 Days)
  • CVRX 516.1K
  • CPSS 12.5K
  • Earning Date
  • CVRX 05-08-2025
  • CPSS 05-12-2025
  • Dividend Yield
  • CVRX N/A
  • CPSS N/A
  • EPS Growth
  • CVRX N/A
  • CPSS N/A
  • EPS
  • CVRX N/A
  • CPSS 0.79
  • Revenue
  • CVRX $52,870,000.00
  • CPSS $188,776,000.00
  • Revenue This Year
  • CVRX $13.92
  • CPSS $146.82
  • Revenue Next Year
  • CVRX $19.89
  • CPSS $18.24
  • P/E Ratio
  • CVRX N/A
  • CPSS $11.45
  • Revenue Growth
  • CVRX 25.62
  • CPSS N/A
  • 52 Week Low
  • CVRX $4.30
  • CPSS $7.85
  • 52 Week High
  • CVRX $18.55
  • CPSS $12.73
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 44.02
  • CPSS 50.32
  • Support Level
  • CVRX $6.08
  • CPSS $8.78
  • Resistance Level
  • CVRX $7.17
  • CPSS $9.15
  • Average True Range (ATR)
  • CVRX 0.57
  • CPSS 0.28
  • MACD
  • CVRX 0.14
  • CPSS -0.01
  • Stochastic Oscillator
  • CVRX 65.03
  • CPSS 31.94

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: